Search Results - "Kurland, Brenda"

Whole‐Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α‐18F‐Fluoro‐17β‐Estradiol Positron Emission Tomography: Meta‐Analysis and Recommendations for Integration into Clinical Applications by Kurland, Brenda F., Wiggins, Jay R., Coche, Amandine, Fontan, Charlotte, Bouvet, Yann, Webner, Peter, Divgi, Chaitanya, Linden, Hannah M.

“…Estrogen receptor (ER) status by immunohistochemistry (IHC) of cancer tissue is currently used to direct endocrine therapy in breast cancer. Positron emission…”
Get full text

Radiomic Analysis: Study Design, Statistical Analysis, and Other Bias Mitigation Strategies by Moskowitz, Chaya S, Welch, Mattea L, Jacobs, Michael A, Kurland, Brenda F, Simpson, Amber L

“…Rapid advances in automated methods for extracting large numbers of quantitative features from medical images have led to tremendous growth of publications…”
Get full text

Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment by Raunig, David L, McShane, Lisa M, Pennello, Gene, Gatsonis, Constantine, Carson, Paul L, Voyvodic, James T, Wahl, Richard L, Kurland, Brenda F, Schwarz, Adam J, Gönen, Mithat, Zahlmann, Gudrun, Kondratovich, Marina V, O’Donnell, Kevin, Petrick, Nicholas, Cole, Patricia E, Garra, Brian, Sullivan, Daniel C

“…Technological developments and greater rigor in the quantitative measurement of biological features in medical images have given rise to an increased interest…”
Get full text

Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients by Wang, Peilu, Bahreini, Amir, Gyanchandani, Rekha, Lucas, Peter C, Hartmaier, Ryan J, Watters, Rebecca J, Jonnalagadda, Amruth R, Trejo Bittar, Humberto E, Berg, Aaron, Hamilton, Ronald L, Kurland, Brenda F, Weiss, Kurt R, Mathew, Aju, Leone, Jose Pablo, Davidson, Nancy E, Nikiforova, Marina N, Brufsky, Adam M, Ambros, Tadeu F, Stern, Andrew M, Puhalla, Shannon L, Lee, Adrian V, Oesterreich, Steffi

“…Given the clinical relevance of ESR1 mutations as potential drivers of resistance to endocrine therapy, this study used sensitive detection methods to…”
Get full text

Heterogeneity in Metastatic Breast Cancer 18F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating? by Kurland, Brenda F, Oesterreich, Steffi

Get full text

Heterogeneity in Metastatic Breast Cancer 18 F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating? by Kurland, Brenda F, Oesterreich, Steffi

Get full text

Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer by Kurland, Brenda F, Peterson, Lanell M, Lee, Jean H, Schubert, Erin K, Currin, Erin R, Link, Jeanne M, Krohn, Kenneth A, Mankoff, David A, Linden, Hannah M

“…F-fluoroestradiol (FES) PET scans measure regional estrogen binding, and F-fluorodeoxyglucose (FDG) PET measures tumor glycolytic activity. We examined…”
Get full text

Quantitative Diffusion-Weighted Imaging as an Adjunct to Conventional Breast MRI for Improved Positive Predictive Value by Partridge, Savannah C, DeMartini, Wendy B, Kurland, Brenda F, Eby, Peter R, White, Steven W, Lehman, Constance D

“…The purpose of our study was to investigate whether adding diffusion-weighted imaging (DWI) to dynamic contrast-enhanced MRI (DCE-MRI) could improve the…”
Get full text

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial by MARTINS, Renato G, PARVATHANENI, Upendra, MENDEZ, Eduardo, FUTRAN, Neal, WANG, David X, XIAOYU CHAI, WALLACE, Sarah G, AUSTIN, Melissa, SCHMIDT, Rodney, HAYES, D. Neil, BAUMAN, Julie E, SHARMA, Anand K, RAEZ, Luis E, PAPAGIKOS, Michael A, YUNUS, Furhan, KURLAND, Brenda F, EATON, Keith D, LIAO, Jay J

“…The combination of cisplatin and radiotherapy is a standard treatment for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)…”
Get full text

Combined VLA-4-Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma by Choi, Jaeyeon, Beaino, Wissam, Fecek, Ronald J, Fabian, Kellsye P L, Laymon, Charles M, Kurland, Brenda F, Storkus, Walter J, Anderson, Carolyn J

“…Very late antigen-4 (VLA-4; also known as integrin α β ) is expressed at high levels in aggressive and metastatic melanoma tumors and may provide an ideal…”
Get full text

Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence by Volonte, Daniela, Vyas, Avani R., Chen, Chen, Dacic, Sanja, Stabile, Laura P., Kurland, Brenda F., Abberbock, Shira R., Burns, Timothy F., Herman, James G., Di, Yuanpu Peter, Galbiati, Ferruccio

“…Oncogene-induced senescence (OIS) is considered a powerful tumor suppressor mechanism. Caveolin-1 acts as a scaffolding protein to functionally regulate…”
Get full text

Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer by Mrugala, Maciej M., Kim, Bryan, Sharma, Akanksha, Johnson, Natalie, Graham, Carrie, Kurland, Brenda F., Gralow, Julie

“…Metastatic breast cancer frequently leads to brain metastases and, less commonly, leptomeningeal carcinomatosis (LC). Once cerebrospinal fluid involvement…”
Get full text

Prospective Neurocognitive Function Over 5 Years After Allogeneic Hematopoietic Cell Transplantation for Cancer Survivors Compared With Matched Controls at 5 Years by SYRJALA, Karen L, ARTHERHOLT, Samantha B, KURLAND, Brenda F, LANGER, Shelby L, ROTH-ROEMER, Sari, BROECKEL ELROD, Joann, DIKMEN, Sureyya

“…Research has documented cognitive deficits both before and after high-dose treatment followed by allogeneic hematopoietic cell transplantation (HCT), with…”
Get full text

Use of Response Permutation to Measure an Imaging Dataset’s Susceptibility to Overfitting by Selected Standard Analysis Pipelines by Chakraborty, Jayasree, Midya, Abhishek, Kurland, Brenda F., Welch, Mattea L., Gonen, Mithat, Moskowitz, Chaya S., Simpson, Amber L.

“…This study demonstrates a method for quantifying the impact of overfitting on the receiving operator characteristic curve (AUC) when using standard analysis…”
Get full text

Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in KRAS- Mutant NSCLC Is Mediated via Reactivation of the ERK-p90RSK-mTOR Signaling Network by Chatterjee, Suman, Huang, Eric H-B, Christie, Ian, Kurland, Brenda F, Burns, Timothy F

“…Approximately 25% of non-small cell lung cancer (NSCLC) patients have mutations, and no effective therapeutic strategy exists for these patients. The use of…”
Get full text

Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes? by Shiffman, Saul, Mao, Jason M., Kurland, Brenda F., Scholl, Sarah M.

“…Rationale The Food and Drug Administration is considering severely restricting the nicotine in cigarettes, to reduce smoking. A study showed that non-daily,…”
Get full text

For Health-Related Quality of Life and Other Longitudinal Data, Analysis Should Distinguish Between Truncation by Death and Data Missing Because of Nonresponse by Kurland, Brenda F, Egleston, Brian L

Get full text

Comparison of PD‐L1 immunohistochemistry assays and response to PD‐1/L1 inhibitors in advanced non‐small‐cell lung cancer in clinical practice by Villaruz, Liza C, Ancevski Hunter, Katerina, Kurland, Brenda F, Abberbock, Shira, Herbst, Cameron, Dacic, Sanja

“…Aims Several studies have demonstrated analytical comparability between different PD‐L1 assays, but their clinical validity in non‐small‐cell lung cancer in…”
Get full text

Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer by Stabile, Laura P, Farooqui, Mariya, Kanterewicz, Beatriz, Abberbock, Shira, Kurland, Brenda F, Diergaarde, Brenda, Siegfried, Jill M

“…A hormonal role in NSCLC development is well documented. We previously showed that the aromatase inhibitor (AI) anastrozole decreased development of tobacco…”
Get more information

Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease by Price, Joseph L, McKeel, Daniel W, Buckles, Virginia D, Roe, Catherine M, Xiong, Chengjie, Grundman, Michael, Hansen, Lawrence A, Petersen, Ronald C, Parisi, Joseph E, Dickson, Dennis W, Smith, Charles D, Davis, Daron G, Schmitt, Frederick A, Markesbery, William R, Kaye, Jeffrey, Kurlan, Roger, Hulette, Christine, Kurland, Brenda F, Higdon, Roger, Kukull, Walter, Morris, John C

“…Abstract Objective To determine the frequency and possible cognitive effect of histological Alzheimer's disease (AD) in autopsied older nondemented…”
Get full text